Skip to main content

Actinic Keratosis Content

Can you identify this statement about tirbanibulin and actinic keratosis as true or false?
Derm Q&A
Jessica Garlewicz, Associate Digital Editor
New therapies for actinic keratosis, such as a novel ointment currently in being tested in clinical trials, may offer alternative options for treatments of precancerous lesions.
A study published in the Journal of Dermatological Treatment aimed to compare the time of skin healing and side effects in omnivores and vegans treated with photodynamic therapy (PDT) for actinic keratosis (AK).
A study published in New England Journal of Medicine found tirbanibulin was superior to vehicle as a topical treatment for actinic keratoses but was associated with transient localized reactions and recurrence at 1 year.
A recent study assessed the real-world safety and effectiveness of field- and lesion-directed treatments for actinic keratoses.
Derm Dx
Hannah J. Anderson, MD, Barbara B. Wilson, MD, Richard H. Flowers, MD, Amor Khachemoune, MD, FAAD, FACMS, Section Editor
In case two, a 62-year-old man was prescribed ingenol mebutate 0.015% for actinic keratoses on the temples, cheeks, nose, and helices. On day three of treatment, he presented with brightly erythematous patches on the malar cheeks and nose with numerous overlying minute superficial pustules.
Findings from a recent study showed using ablative fractional lasers may improve the efficacy of photodynamic therapy for the treatment of actinic keratoses.
Findings from a cross-sectional study support the use of sun protective measures among outdoor workers, as work-related UV exposure was associated with an increased occurrence of both facial wrinkles and actinic keratoses.
Results of a recent study showed ingenol mebutate was effective for treating larger fields of actinic keratoses areas on the face, scalp, and chest.

Researchers investigated whether a topical DNA repair enzyme lip balm containing T4 endonuclease effectively treated actinic cheilitis.
Back to Top